(CNSX:ESAU),(Other OTC:ESAUF),(CNSX:ESAU.CN), This article has been disseminated on behalf of ESGold Corp., which may include a paid advertisement. AUSTIN, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) — NetworkNewsWire Editorial Coverage: Artificial intelligence may be driven by algorithms and code, but its hardware backbone depends on gold and silver — the same precious metals that connect every […]
(NASDAQ:FGL), SELANGOR, Malaysia, Nov. 12, 2025 (GLOBE NEWSWIRE) — Founder Group Limited (“FGL” or the “Company”), today announced that on November 6, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the closing bid price of its Class A Ordinary
PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) — Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain barrier (BBB)-crossing platform technology in lysosomal storage disorders (LSD) to address challenging disease areas with high unmet need. “This agreement underscores our continued
(NASDAQ:TBH), NEW YORK and MIAMI, Nov. 12, 2025 (GLOBE NEWSWIRE) — Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House”) and its merger partner, House of Doge Inc. (“House of Doge”), the official corporate arm of the Dogecoin Foundation, today highlighted a new feature interview with Chairman and CEO Lavell Juan Malloy II, published by Impact
(NASDAQ:DFDV), BOCA RATON, FL, Nov. 12, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that, subject to market and other conditions, it intends to offer, in a public offering registered
(NASDAQ:TRON), -Over $239 million in Shareholders' Equity-Net Income of $12,174,266 Winter Park, Florida, Nov. 12, 2025 (GLOBE NEWSWIRE) — Tron Inc. (Nasdaq: TRON) (the “Company”), an innovation leader at the intersection of blockchain, entertainment and digital assets, announced financial results for the fiscal quarter ending on September 30, 2025, in its Form 10-Q filed with
(TSX:PRN),(NASDAQ:PROF), TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, announced today that it has entered into an exclusive distribution and supply agreement for its TULSA-PRO(R) system with Getz
(NASDAQ:IOBT), NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences: Event: Jefferies Global Healthcare ConferenceLocation: LondonPresentation: Tuesday, November 18, 2025, at 3:00 PM GMT
(NASDAQ:RMCF), DURANGO, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory is thrilled to announce the grand opening of its entirely new prototype store on King Street, taking place the weekend of November 13-15. This marks the debut of a fresh design and experience concept for the beloved brand–one that engages all five
(NASDAQ:INDP), NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announces financial results for the third quarter ended September 30, 2025, and provides a corporate update. Jeffrey Meckler, Indaptus Therapeutics' Chief Executive